Berbamine (BBM) has been reported to play an important role in the anti-inflammatory and anti-neoplastic activities.
However, whether BBM mediates the anti-tumor efficacy in renal cell carcinoma (RCC) cells and the potential molecular mechanisms remain unclear.
